Details for New Drug Application (NDA): 091549
✉ Email this page to a colleague
The generic ingredient in INDOMETHACIN is indomethacin sodium. There are fifteen drug master file entries for this compound. Additional details are available on the indomethacin sodium profile page.
Summary for 091549
Tradename: | INDOMETHACIN |
Applicant: | Amneal Pharms |
Ingredient: | indomethacin |
Patents: | 0 |
Pharmacology for NDA: 091549
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 091549
Suppliers and Packaging for NDA: 091549
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
INDOMETHACIN | indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 091549 | ANDA | Amneal Pharmaceuticals LLC | 65162-506 | 65162-506-03 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-506-03) |
INDOMETHACIN | indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 091549 | ANDA | Amneal Pharmaceuticals LLC | 65162-506 | 65162-506-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65162-506-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 75MG | ||||
Approval Date: | Dec 1, 2010 | TE: | AB | RLD: | No |
Complete Access Available with Subscription